Drug Shortage Report for ADALAT XL
Report ID | 48932 |
Drug Identification Number | 02237618 |
Brand name | ADALAT XL - SRT 20MG |
Common or Proper name | Nifedipine extended-release tablets Bayer Standard |
Company Name | BAYER INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NIFEDIPINE |
Strength(s) | 20MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 28's and 98's |
ATC code | C08CA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-05-09 |
Estimated end date | 2018-09-15 |
Actual end date | 2018-08-14 |
Shortage status | Resolved |
Updated date | 2018-08-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-08-15 | French | Compare |
v4 | 2018-08-15 | English | Compare |
v3 | 2018-05-10 | English | Compare |
v2 | 2018-05-09 | French | Compare |
v1 | 2018-05-09 | English | Compare |
Showing 1 to 5 of 5